Clinical Research
News & Careers
Search the Site
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login           Employers:  Register | Login   

By Industry | By Industry Segment | By Services and Suppliers | By Location | Profile Search
 Company Profile



Phone: n/a Fax: n/a


AbbVie (NYSE:ABBV) is a global, research-based biopharmaceutical company formed in 2013 following separation from Abbott Laboratories. The company's mission is to use its expertise, dedicated people and unique approach to innovation to develop and market advanced therapies that address some of the world's most complex and serious diseases. AbbVie employs approximately 25,000 people worldwide and markets medicines in more than 170 countries.

 Key Statistics

Ownership: Public

Web Site: AbbVie
Symbol: ABBV


 Company News
AbbVie (ABBV) Nabs Positive CHMP Opinions For VIEKIRAX Plus EXVIERA To Treat HCV 11/21/2014 7:20:39 AM
AbbVie (ABBV) Acquires Manufacturing Facility In Singapore; Further Expands Capabilities In Asia 11/21/2014 5:50:39 AM
Paulson Opens New Stake In AbbVie (ABBV), Nearly Triples Shire Shares 11/18/2014 7:43:15 AM
AbbVie (ABBV)To Present Data On Investigational Oncology Compounds At The 56th American Society of Hematology Annual Meeting 11/17/2014 12:19:41 PM
AbbVie (ABBV) To Present At Jefferies and Co. 2014 Global Healthcare Conference 11/17/2014 11:45:50 AM
AbbVie (ABBV) Presents Results From Study Of ABT-414 In Patients With Glioblastoma Multiforme At The 19th Annual Scientific Meeting And Education Day Of The Society For Neuro-Oncology 11/17/2014 10:27:38 AM
Ablynx (ABLYF) To Present Data On Its Anti-Il-6r Nanobody, Developed In Partnership With AbbVie (ABBV), At The American College of Rheumatology Annual Meeting 11/14/2014 10:30:41 AM
Next Generation Researchers Recognized In The AbbVie (ABBV) Student Poster Awards 11/13/2014 11:38:56 AM
AbbVie (ABBV)'s Leadership In Immunology Featured At 2014 American College of Rheumatology Annual Meeting With New Data On Investigational Medicines And HUMIRA® (adalimumab) 11/13/2014 10:01:21 AM
AbbVie (ABBV) Uses Patents To Ambush Gilead Sciences, Inc. (GILD) 11/13/2014 6:40:25 AM